{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:29:01Z","timestamp":1794277741863,"version":"4.9.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["BM1202"],"award-info":[{"award-number":["BM1202"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000098","name":"Stem Cell Network","doi-asserted-by":"publisher","award":["031B0332B"],"award-info":[{"award-number":["031B0332B"]}],"id":[{"id":"10.13039\/501100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["EFRE-0800396"],"award-info":[{"award-number":["EFRE-0800396"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jcyt.2023.03.009","type":"journal-article","created":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T00:32:57Z","timestamp":1682209977000},"page":"847-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Qualification of a multidonor mixed lymphocyte reaction assay for the functional characterization of immunomodulatory extracellular vesicles"],"prefix":"10.1016","volume":"25","author":[{"given":"Michel","family":"Bremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Nardi Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Tertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8230-2218","authenticated-orcid":false,"given":"Verena","family":"B\u00f6rger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2446-948X","authenticated-orcid":false,"given":"Bernd","family":"Giebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2023.03.009_bib0001","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Yanez-Mo","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071450","article-title":"Mesenchymal stem\/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents","volume":"18","author":"B\u00f6rger","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0003","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/ni854","article-title":"Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes","volume":"3","author":"Thery","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0004","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1172\/JCI81136","article-title":"Exosomes and tumor-mediated immune suppression","volume":"126","author":"Whiteside","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1071008","article-title":"Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC","volume":"5","author":"Besse","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-3-10","article-title":"Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial","volume":"3","author":"Escudier","year":"2005","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-3-9","article-title":"A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer","volume":"3","author":"Morse","year":"2005","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0008","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.21037\/sci.2017.09.06","article-title":"Clinical potential of mesenchymal stem\/stromal cell-derived extracellular vesicles","volume":"4","author":"Giebel","year":"2017","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0010","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2008070798","article-title":"Mesenchymal stem cell-derived microvesicles protect against acute tubular injury","volume":"20","author":"Bruno","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0011","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0012","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40824-016-0068-0","article-title":"Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases","volume":"20","author":"Nassar","year":"2016","journal-title":"Biomater Res"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0014","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0015","doi-asserted-by":"crossref","first-page":"e12094","DOI":"10.1002\/jev2.12094","article-title":"First-in-human intracochlear application of human stromal cell-derived extracellular vesicles","volume":"10","author":"Warnecke","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0016","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcyt.2021.01.001","article-title":"Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles","volume":"23","author":"Gimona","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0017","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0018","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.bbmt.2011.09.003","article-title":"Mesenchymal stromal cells: a new tool against graft-versus-host disease?","volume":"18","author":"Baron","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0019","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","article-title":"The mesenchymal stromal cells dilemma\u08e7does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?","volume":"15","author":"Galipeau","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0020","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbmt.2019.08.029","article-title":"A phase 3 randomized study of remestemcel-L versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease","volume":"26","author":"Kebriaei","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0021","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2020.01.018","article-title":"A phase 3, single-arm, prospective study of remestemcel-L, ex vivo culture-expanded adult human mesenchymal stromal cells for the treatment of pediatric patients who failed to respond to steroid treatment for acute graft-versus-host disease","volume":"26","author":"Kurtzberg","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0022","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bbmt.2020.01.026","article-title":"Study 275: updated expanded access program for remestemcel-L in steroid-refractory acute graft-versus-host disease in children","volume":"26","author":"Kurtzberg","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0023","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0024","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/jcb.24166","article-title":"Functional heterogeneity of mesenchymal stem cells: implications for cell therapy","volume":"113","author":"Phinney","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8","article-title":"Donor variation in the growth properties and osteogenic potential of human marrow stromal cells","volume":"75","author":"Phinney","year":"1999","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0026","first-page":"126","article-title":"Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells","volume":"88","author":"Vogel","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2021.03.069","article-title":"Strategies to address mesenchymal stem\/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies","author":"Dunn","year":"2021","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0028","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jcyt.2020.11.007","article-title":"Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition","volume":"23","author":"Galipeau","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0029","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/15384101.2015.1128591","article-title":"Human mesenchymal and murine stromal cells support human lympho-myeloid progenitor expansion but not maintenance of multipotent haematopoietic stem and progenitor cells","volume":"15","author":"Radtke","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0030","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5966\/sctm.2015-0078","article-title":"Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression","volume":"4","author":"Doeppner","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0031","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbi.2016.11.011","article-title":"Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury","volume":"60","author":"Drommelschmidt","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0032","doi-asserted-by":"crossref","first-page":"754","DOI":"10.5966\/sctm.2015-0197","article-title":"Mesenchymal stromal cell-derived extracellular vesicles protect the fetal brain after hypoxia-ischemia","volume":"5","author":"Ophelders","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0033","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00395-021-00881-9","article-title":"Small extracellular vesicles obtained from hypoxic mesenchymal stromal cells have unique characteristics that promote cerebral angiogenesis, brain remodeling and neurological recovery after focal cerebral ischemia in mice","volume":"116","author":"Gregorius","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.601176","article-title":"Mesenchymal stromal cell-derived extracellular vesicles reduce neuroinflammation, promote neural cell proliferation and improve oligodendrocyte maturation in neonatal hypoxic-ischemic brain injury","volume":"14","author":"Kaminski","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2023.03.008","article-title":"Independent human mesenchymal stromal cell-derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host-disease model","author":"Madel","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0036","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3390\/biomedicines9121864","article-title":"Anti-inflammatory mesenchymal stromal cell-derived extracellular vesicles improve pathology in Niemann-Pick type C disease","volume":"9","author":"Van Hoecke","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0037","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/STROKEAHA.119.028012","article-title":"Mesenchymal stromal cell-derived small extracellular vesicles induce ischemic neuroprotection by modulating leukocytes and specifically neutrophils","volume":"51","author":"Wang","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0038","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/ijms20071642","article-title":"Individual immune-modulatory capabilities of MSC-derived extracellular vesicle (EV) preparations and recipient-dependent responsiveness","volume":"20","author":"Kordelas","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.981061","article-title":"Perinatal derivatives: How to best validate their immunomodulatory functions","volume":"10","author":"Papait","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13287-015-0233-8","article-title":"A robust potency assay highlights significant donor variation of human mesenchymal stem\/progenitor cell immune modulatory capacity and extended radio-resistance","volume":"6","author":"Ketterl","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071413","article-title":"An in vitro potency assay for monitoring the immunomodulatory potential of stromal cell-derived extracellular vesicles","volume":"18","author":"Pachler","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0042","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jcyt.2022.09.006","article-title":"CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilities","volume":"25","author":"Nardi Bauer","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0043","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1182\/blood-2006-11-055921","article-title":"Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins","volume":"109","author":"Beckmann","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0044","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2004-02-0511","article-title":"Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells","volume":"104","author":"Giebel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0045","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1002\/cpsc.128","article-title":"Scaled isolation of mesenchymal stem\/stromal cell-derived extracellular vesicles","volume":"55","author":"B\u00f6rger","year":"2020","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0046","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1528109","article-title":"Precipitation with polyethylene glycol followed by washing and pelleting by ultracentrifugation enriches extracellular vesicles from tissue culture supernatants in small and large scales","volume":"7","author":"Ludwig","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0047","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0048","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1587567","article-title":"Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material","volume":"8","author":"Gorgens","year":"2019","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0049","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.colsurfb.2011.05.013","article-title":"Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy","volume":"87","author":"Sokolova","year":"2011","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0050","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/j.1600-6143.2009.02742.x","article-title":"Contribution of naive and memory T-cell populations to the human alloimmune response","volume":"9","author":"Macedo","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0051","doi-asserted-by":"crossref","first-page":"272ra210","DOI":"10.1126\/scitranslmed.3010760","article-title":"Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients","volume":"7","author":"Morris","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0052","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.exphem.2006.03.001","article-title":"Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering","volume":"34","author":"Scheinberg","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0053","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4049\/jimmunol.166.2.973","article-title":"Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question","volume":"166","author":"Suchin","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0054","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.transproceed.2012.01.038","article-title":"Optimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients","volume":"44","author":"Tanaka","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cyto.990150104","article-title":"Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry","volume":"15","author":"Schmid","year":"1994","journal-title":"Cytometry"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0056","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jim.2004.07.006","article-title":"Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function","volume":"293","author":"Reddy","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113940","article-title":"Scaled preparation of extracellular vesicles from conditioned media","volume":"177","author":"Staubach","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0058","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.4049\/jimmunol.141.11.3868","article-title":"Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal","volume":"141","author":"Ceuppens","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0059","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fimmu.2018.00172","article-title":"Establishment of the reference intervals of lymphocyte function in healthy adults based on IFN-\u03b3 secretion assay upon phorbol-12-myristate-13-acetate\/ionomycin stimulation","volume":"9","author":"Hou","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2023.03.009_bib0060","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.4049\/jimmunol.1303242","article-title":"TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation","volume":"193","author":"Lehnert","year":"2014","journal-title":"J Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923000890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923000890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:35:51Z","timestamp":1778614551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923000890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1465324923000890"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.03.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qualification of a multidonor mixed lymphocyte reaction assay for the functional characterization of immunomodulatory extracellular vesicles","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}